[ET Net News Agency, 12 May 2026] HENGRUI PHARMA (01276) rose 14.4% to HK$75.55.
It hits an intra-day high of HK$76.75, hitting an 1-month high, breaking above the 100-D SMA of HK$68.726, and an intra-day low of HK$65.3. The total shares traded was 5.24 million, with a value of HK$362.93m. The active buy/sell ratio is 70:30, with net buying turnover of HK$139.61m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$15.26m, with volume weighted average price of HK$67.898. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$27.59m, with volume weighted average price of HK$68.016. The stock has risen a combined 17% over the past 2 consecutive trading days.
Basic Information| Nominal | 75.550 | % Chg | +14.38% |
| High | 76.750 | Low | 65.300 |
| Shares Tr | 5.24m | Turnover | 362.93m |
| 10-D SMA | 66.907 | %H.V | 36.924 |
| 20-D SMA | 67.119 | VWAP | 69.279 |
| 50-D SMA | 65.602 | RSI14 | 68.660 |
Status: Breaking above the 100-D SMA, hitting an 1-month high, active buy/sell ratio is 70:30, with net buying turnover of HK$139.61m, rising a combined 17% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HENGRUI PHARMA (01276) | 75.55 | +14.38 |
| SIHUAN PHARM (00460) | 1.17 | -2.50 |
| GRAND PHARMA (00512) | 6.13 | -0.49 |
| SBP GROUP (01177) | 5.76 | +1.77 |
| LIVZON PHARMA (01513) | 27.66 | -0.93 |
| LUYE PHARMA (02186) | 2.55 | -1.92 |
| FOSUN PHARMA (02196) | 19.23 | -0.93 |
| SH PHARMA (02607) | 12.19 | +0.33 |
| CHINARES PHARMA (03320) | 5.21 | -0.57 |
| HANSOH PHARMA (03692) | 36.40 | -0.76 |
(ed)
